• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首次使用原创血液灌流系统的临床经验。

First experience with clinical use of an original hemoperfusion system.

作者信息

Horký J, Horák J, Tlustáková M, Kálal J

出版信息

Czech Med. 1981;4(1-2):67-80.

PMID:7261808
Abstract
  1. The authors present their experience with the use of an original charcoal hemoperfusion system Hemosorb in clinical application, in 9 patients with a heavy metabolic disturbance (failure of the liver and kidney) and after an intoxication with drugs. 2. In two patients the consciousness was remarkably recovered and in one patient it was improved already in the course of the hemoperfusion process, in further two cases the consciousness was recovered in short time after the Hemosorb was used, 7 were completely healed. 3. During the hemoperfusion with Hemosorb there were no symptoms of bad tolerance and no complications except for temporary pyretic reaction in one case. In unique cases manifestations of an enhanced bleeding occurred at the end of the long-term process, which were, however, rather easily corrected. The drop of thrombocytes was essentially reasonable and their restriction after the hemoperfusion was good. 4. Out of metabolic parameters of interest, in the patients with the heavy metabolic failure the drop of total phenol substances, uric acid and creatinine in the blood serum were observed at first stages of the hemoperfusion. The clearance of the total phenol substances and creatinine in the hemoperfusion system was ever rather high. 5. In a patient intoxicated with drugs, there was a remarkable drop of the metaqualone in the blood serum in the course of the hemoperfusion with Hemosorb; the clearance of this compound in the hemoperfusion system was still high after 4 hrs. 6. The first experiences with the clinical application of a new, original hemoperfusion system demonstrated its non-harmful character and biocompatibility as well as clinical, metabolic and toxicologic efficiency.
摘要
  1. 作者介绍了他们使用原创的血液灌流系统Hemosorb的临床经验,该系统应用于9例重度代谢紊乱(肝肾衰竭)及药物中毒患者。2. 2例患者意识明显恢复,1例在血液灌流过程中意识即有所改善,另外2例在使用Hemosorb后短时间内意识恢复,7例完全治愈。3. 使用Hemosorb进行血液灌流期间,除1例出现短暂发热反应外,未出现耐受性差的症状及并发症。在个别长期治疗过程结束时出现了出血倾向增强的表现,但很容易纠正。血小板计数下降基本合理,血液灌流后其恢复情况良好。4. 在重度代谢衰竭患者关注的代谢参数方面,血液灌流初期观察到血清中总酚类物质、尿酸和肌酐水平下降。血液灌流系统对总酚类物质和肌酐的清除率一直较高。5. 在1例药物中毒患者中,使用Hemosorb进行血液灌流过程中血清中安眠酮水平显著下降;4小时后该化合物在血液灌流系统中的清除率仍较高。6. 新型原创血液灌流系统的首次临床应用经验表明了其无害性、生物相容性以及临床、代谢和毒理学疗效。

相似文献

1
First experience with clinical use of an original hemoperfusion system.首次使用原创血液灌流系统的临床经验。
Czech Med. 1981;4(1-2):67-80.
2
Clinical experience with prolonged combined hemoperfusion-hemodialysis treatment of severe poisoning.重度中毒的长时间血液灌流联合血液透析治疗的临床经验
Artif Organs. 1981 Feb;5(1):59-66.
3
[The use of haemocol hemoperfusion].
Wien Klin Wochenschr Suppl. 1978;89:1-12.
4
Biological evaluation of hemoperfusion in acute poisoning.
Dev Toxicol Environ Sci. 1980;8:377-85.
5
[Treatment of patients with acute digitalis poisoning by charcoal hemoperfusion].[用活性炭血液灌流治疗急性洋地黄中毒患者]
Vutr Boles. 1987;26(5):46-50.
6
Successful treatment of phenol poisoning with charcoal hemoperfusion.
Vet Hum Toxicol. 1996 Feb;38(1):27-8.
7
[Paraquat intoxication and hemocarboperfusion].[百草枯中毒与血液灌流]
Acta Med Port. 2005 Nov-Dec;18(6):423-31. Epub 2006 Mar 6.
8
Biological evaluation of hemoperfusion in acute poisoning.
Clin Toxicol. 1981 Oct;18(10):1213-23. doi: 10.3109/00099308109035060.
9
[Effect of hemoperfusion in treatment of children with acute poisoning].血液灌流治疗小儿急性中毒的疗效观察
Zhonghua Er Ke Za Zhi. 2007 Sep;45(9):665-9.
10
[Accelerated elimination using hemoperfusion in a patient with phenobarbital intoxication].[使用血液灌流加速苯巴比妥中毒患者的清除]
Ned Tijdschr Geneeskd. 2004 Aug 14;148(33):1642-5.